KEY FEATURES
| Full Name | Proislet Amyloid Polypeptide |
|---|---|
| Synonym | Pro-IAPP; Pro-Amylin; Pro-Islet Amyloid Polypeptide |
| Assay Type | Competitive |
| Reactivity | Human |
| Range | 24.69-2000pg/mL |
| Sensitivity | 8.81pg/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 50μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human ProIAPP in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Competitive-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with Human ProIAPP. During the reaction, Human ProIAPP in the sample or standard competes with a fixed amount of Human ProIAPP on the solid phase supporter for sites on the Biotinylated Detection Ab specific to Human ProIAPP. Excess conjugate and unbound sample or standard are washed away, and Avidin-Horseradish Peroxidase (HRP) conjugate are added to each micro plate well and incubated. Then a TMB substrate solution is added to each well. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns from blue to yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The concentration of Human ProIAPP in tested samples can be calculated by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES
TYPICAL DATA
Human ProIAPP ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (pg/mL) | 101.8 | 250.81 | 746.6 | 99.32 | 257.22 | 801.33 |
| Standard deviation | 5.41 | 13.39 | 27.62 | 6.74 | 12.66 | 29.09 |
| CV(%) | 5.31 | 5.34 | 3.7 | 6.79 | 4.92 | 3.63 |
RECOVERY
The recovery of Human ProIAPP spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 85-100 | 91 |
| EDTA plasma (n=8) | 96-108 | 101 |
| Cell culture media (n=8) | 93-108 | 100 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human ProIAPP in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.
Products associated with PRL ELISA Kits
| PRLR ELISA Kit | publications with PRL and PRLR |
Pathways associated with PRL ELISA Kit
| Amyloids Pathway | Amyloids Pathway |
| Cytokine Signaling In Immune System Pathway | Cytokine Signaling In Immune System Pathway |
| Cytokine-cytokine Receptor Interaction Pathway | Cytokine-cytokine Receptor Interaction Pathway |
| Disease Pathway | Disease Pathway |
| ErbB4 Signaling Events Pathway | ErbB4 Signaling Events Pathway |
| Glucocorticoid Receptor Regulatory Network Pathway | Glucocorticoid Receptor Regulatory Network Pathway |
| Growth Hormone Receptor Signaling Pathway | Growth Hormone Receptor Signaling Pathway |
| Immune System Pathway | Immune System Pathway |
| Jak-STAT Signaling Pathway | Jak-STAT Signaling Pathway |
Diseases associated with PRL ELISA Kit
| Pituitary Neoplasms | publications with PRL and Pituitary Neoplasms |
| Hyperprolactinemia | publications with PRL and Hyperprolactinemia |
| Adenoma | publications with PRL and Adenoma |
| Prolactinoma | publications with PRL and Prolactinoma |
| Mental Disorders | publications with PRL and Mental Disorders |
| Amenorrhea | publications with PRL and Amenorrhea |
| Galactorrhea | publications with PRL and Galactorrhea |
| Growth Hormone-Secreting Pituitary Adenoma | publications with PRL and Growth Hormone-Secreting Pituitary Adenoma |
| Hypogonadism | publications with PRL and Hypogonadism |
| Puerperal Disorders | publications with PRL and Puerperal Disorders |
Organs/Tissues associated with PRL ELISA Kit
| Testis | publications with PRL and Testis |
| Uncharacterized Tissue | publications with PRL and Uncharacterized Tissue |
